U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07092852) titled 'PGx Medication Safety Reviews of Persons With IDD' on July 08.
Brief Summary: The purpose of this study is to assess the feasibility of a comprehensive medication review and PGx initiative as part of the care process for individuals in the care of CP Unlimited. This initiative may help improve management of medications and overall health and well-being for participating individuals. Please note that in the context of the research being conducted, all information will remain confidential and deidentified for analyses.
Under the proposed study protocol, CP Unlimited, in partnership with pharmacists at GalenusRx, will implement and as...